We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.

Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.

Learn more about who we are
CUREator is an Australian national biotechnology incubator supporting the development of pre-clinical and clinical stage medical innovation.

Portfolio

We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 50 companies to date.

Que Oncology
Que Oncology

A clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy

View Project
CatalYm
CatalYm

Reversing GDF-15-mediated immunosupression to induce anti-tumour responses

View Project
NRG Therapeutics
NRG Therapeutics

Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders

View Project
Pheon Therapeutics
Pheon Therapeutics

Developing first-in-class ADCs to treat cancer

View Project
Currus Biologics
Currus Biologics

Developing the next generation of CAR-T cell therapies to treat solid cancers

View Project
Allay Therapeutics
Allay Therapeutics

Combining non-opioid analgesics and biopolymers to deliver weeks of localised pain management

View Project
Myricx Pharma
Myricx Pharma

Unlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections

View Project
Glyscend
Glyscend

Glyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.

View Project
See all

Members

Brandon BioCatalyst brings together more than 50 leading medical research institutes across Australia and New Zealand.

Institute
Australian Institute of Tropical Health and Medicine

The Australian Institute of Tropical Health and Medicine (AITHM) is a multi-disciplinary health and tropical medicine research institute located in the tropics. Based at James Cook University in northern Queensland, AITHM has key nodes in Townsville, Cairns and the Torres Strait.

View
Institute
Malaghan Institute of Medical Research

The Malaghan Institute of Medical Research is New Zealand’s leading independent biomedical research institute, with a history spanning over five decades. The Institute’s research centers on the immune system, and how it may be harnessed to treat human disease. Pioneering research programmes explore fields of immunotherapy such as cancer, asthma and allergy, infectious diseases, gut health and brain health.

View
Institute
James Cook University

AITHM is a flagship research institute of James Cook University based in the tropics of northern Australia. Australia’s only dedicated tropical health and medicine research institute, AITHM is focussed on solving problems of importance to the tropics, leading to improvements in health systems and healthcare delivery, improved biosecurity, and enhanced health outcomes for Australians and our neighbouring tropical nations.

View

Membership

Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.

Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.

Learn more